{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:52:22Z","timestamp":1776106342595,"version":"3.50.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,8]]},"DOI":"10.1093\/cid\/ciad079","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T10:59:05Z","timestamp":1676545145000},"page":"1928-1929","source":"Crossref","is-referenced-by-count":4,"title":["The Antimalarial Activity of Tafenoquine in Falciparum Malaria"],"prefix":"10.1093","volume":"76","author":[{"given":"Nicholas J","family":"White","sequence":"first","affiliation":[{"name":"Faculty of Tropical Medicine, Mahidol University , Bangkok , Thailand"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford University , Oxford , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"2023060818532639100_ciad079-B1","first-page":"25","article-title":"Die behandlung der natuerlichen menschlichen malaria-infektionen mit plasmochin","volume":"30","author":"M\u00fchlens","year":"1926","journal-title":"Arch Schiffs-u Tropenhyg"},{"key":"2023060818532639100_ciad079-B2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1475-2875-12-212","article-title":"The metabolism of primaquine to its active metabolite is dependent on CYP 2D6","volume":"12","author":"Pybus","year":"2013","journal-title":"Malar J"},{"key":"2023060818532639100_ciad079-B3","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/s41467-019-11239-0","article-title":"Antimalarial activity of primaquine operates via a two-step biochemical relay","volume":"10","author":"Camarda","year":"2019","journal-title":"Nat Commun"},{"key":"2023060818532639100_ciad079-B4","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83433","article-title":"The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis","volume":"11","author":"Watson","year":"2022","journal-title":"Elife"},{"key":"2023060818532639100_ciad079-B5","volume-title":"Safety of 8-aminoquinoline antimalarial medicines","author":"Recht","year":"2014"},{"key":"2023060818532639100_ciad079-B6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00711-18","article-title":"Population pharmacokinetics of tafenoquine, a novel antimalarial","volume":"62","author":"Thakkar","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060818532639100_ciad079-B7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1802537","article-title":"Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria","volume":"380","author":"Llanos-Cuentas","year":"2019","journal-title":"N Engl J Med"},{"key":"2023060818532639100_ciad079-B8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S2352-4642(21)00328-X","article-title":"Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial","volume":"6","author":"V\u00e9lez","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"2023060818532639100_ciad079-B9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12936-017-1862-4","article-title":"The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg)","volume":"16","author":"Dow","year":"2017","journal-title":"Malar J"},{"key":"2023060818532639100_ciad079-B10","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.44.6.1680-1685.2000","article-title":"Therapeutic responses to different antimalarial drugs in vivax malaria","volume":"44","author":"Pukrittayakamee","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060818532639100_ciad079-B11","first-page":"391","article-title":"The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain)","volume":"46","author":"Arnold","year":"1955","journal-title":"J Lab Clin Med"},{"key":"2023060818532639100_ciad079-B12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021914","article-title":"A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs","volume":"6","author":"McCarthy","year":"2011","journal-title":"PLoS One"},{"key":"2023060818532639100_ciad079-B13","author":"Barber"},{"key":"2023060818532639100_ciad079-B14","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1128\/AAC.04942-14","article-title":"Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR","volume":"59","author":"Marquart","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060818532639100_ciad079-B15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","article-title":"Assessment of the pharmacodynamic properties of antimalarial drugs in vivo","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060818532639100_ciad079-B16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","article-title":"Malaria parasite clearance","volume":"16","author":"White","year":"2017","journal-title":"Malar J"},{"key":"2023060818532639100_ciad079-B17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QCO.0000000000000766","article-title":"Artemisinin and multidrug-resistant Plasmodium falciparum","volume":"34","author":"Dhorda","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"2023060818532639100_ciad079-B18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(18)30596-6","article-title":"Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis","volume":"19","author":"Commons","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2023060818532639100_ciad079-B19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1475-2875-13-51","article-title":"Mass primaquine treatment to eliminate vivax malaria: lessons from the past","volume":"13","author":"Kondrashin","year":"2014","journal-title":"Malar J"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad079\/49209180\/ciad079.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/11\/1928\/50541616\/ciad079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/11\/1928\/50541616\/ciad079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T18:53:45Z","timestamp":1686250425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/11\/1928\/7041294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,2,16]]},"published-print":{"date-parts":[[2023,6,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad079","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,1]]},"published":{"date-parts":[[2023,2,16]]}}}